ReviewTherapeutic advances in drug safety2018

Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Rashmi R Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.